|
| 1 | TABLET,ANTACID UNCOATED CHEWABLE TABS CONTAINING MINIMUM STRENGTH/QUANTITY IN EACH OF THE FOLLOWING: DRIED ALUMINIUM HYDROXIDE GEL I.P 250mg + MAGNESIUM HCL 250mg + MAGNESIUM ALUMINIUM SILICATE HYDRATE 50mg + ACTIVATED DIMETHICONE IP 50mg |
| 2 | TABLET,ALFUZOSIN,SUSTAINED RELEASE,10 mg |
| 3 | TABLET,BETHANECHOL CHLORIDE 25mg |
| 4 | TABLET,BISACODYL IP 5mg |
| 5 | TABLET,DOXAZOSIN 2mg |
| 6 | TABLET,FINASTERIDE 5mg |
| 7 | TAB, MICRONIZED PURIFIED FLAVONOID FRACTION 500MG |
| 8 | TABLET,FLAVOXATE 200mg |
| 9 | TABLET,HYOSCINE BUTYLBROMIDE 10mg |
| 10 | H-PYLORI KIT,LANSOPRAZOLE 30mg + TINIDAZOLE 500mg + CLARITHROMYCIN 250mg,6/KIT |
| 11 | TABLET,ITOPRIDE HYDROCHLORIDE 50mg |
| 12 | TABLET,LACTIC ACID BACILLUSEACH CONTAINING NOT LESS THAN 60 MILLION SPORES OF LACTOBACILLUS |
| 13 | TABLET,LINEZOLID 600mg |
| 14 | TABLET,MEBEVERINE 135mg |
| 15 | TABLET,MESALAMINE DELAYED RELEASE USP 400mg |
| 16 | TABLET,NITROFURANTOIN 100MG |
| 17 | TABLET,ONDANSETRON 4mg |
| 18 | CAPSULE,PANCREATIC ENZYMES 10000 UNITS,PANCREATIC 150mg + AMYLASE 8000 PH EUR U/U + LIPASE 10000 PH EUR U/U PROTEASE 600PH EUR U/U,MINIMICRO SPHERES |
| 19 | PANTOPRAZOLE 40 MG SCORED |
| 20 | TABLET,SULPHASALAZINE 500mg |
| 21 | TABLET,SOLIFENACIN SUCCINATE 10mg |
| 22 | TABLET,TAMOXIFEN CITRATE 10mg |
| 23 | TABLET,TOLTERADINE TARTRATE 4mg |
| 24 | TABLET,TERBINAFINE 250mg |
| 25 | TABLET,PRUCALOPRIDE 1 MG |
| 26 | TABLET, SULTAMICILLIN 375 MG |
| 27 | TAB. WARFARIN 1MG |
| 28 | TAB. ACOTLAMIDE 100MG |
| 29 | ESOMEPRAZOLE 40 MG ENTERIC COATED |
| 30 | CAPSULE,DUTASTERIDE 0.5mg |
| 31 | CAPSULE,PANCREATIN MINIMICROSPHERES 25000 PH UNITS LIPASE + 18000 PH UNITS AMYLASE + 1000PH UNITS PROTEASE |
| 32 | CAPSULE,TAMSULOSIN 400 MICROGRAM CAP (0.4mg) |
| 33 | CAPSULE, SILODOSIN 8 MG |
| 34 | CAPSULE, ESOMEPRAZOLE 40MG DOMPERIDONE 30MG SUSTAINED RELEASE |
| 35 | INJECTION,AMPICILLIN 1g + SULBACTUM 0.5g |
| 36 | INJECTION,CEFUROXIME SODIUM 1.5g |
| 37 | INJECTION,CEFUROXIME SODIUM 750mg |
| 38 | INJECTION,HYOSCINE BUTYL BROMIDE,1ml/AMP |
| 39 | INJECTION,MENADIONE SODIUM BISULPHITE IP 10mg/ml AMP OF 1ml |
| 40 | INJECTION,MEROPENEM 1g |
| 41 | INJECTION,MEROPENEM 500mg |
| 42 | INJECTION,PANTOPRAZOLE 40mg |
| 43 | INJECTION,TERLIPRESSIN 1mg/10ml |
| 44 | INJECTION,TRIAMCINOLONE ACETONIDE 10mg/1ml,VIAL OF 1ml |
| 45 | SOLUTION, HEPARIN SODIUM TOPICAL SOLUTION 1000 U/ML, VIAL OF 5ML |
| 46 | CREAM,BETAMETHASONE DIPROPIONATE + PHENYLEPHRINE HYDROCHLORIDE IP 0.10% W/W+ LIGNOCAIN HYDROCHLORIDE 2.5% W/W+CHLOROCRESOL IP 0.1% W/W,20g/TUBE |
| 47 | CREAM,FUCIDIC ACID CREAM 2% W/W,10g/TUBE |
| 48 | JELLY,HEPARIN,EACH GRAM CONTAINS HEPARIN SODIUM IP 200 I.U ETHANOL 95% IP 0.5g ETHANOL CONTENT 54% V/V,20g/TUBE |
| 49 | JELLY,LIGNOCAINE HCL,2% W/V IN A STERILE PACKING 30g/TUBE |
| 50 | CREAM,MUPIROCIN OINTMENT (2% W/W) IN WATER SOLUBLE BASE PREFERRED PACK,5g/TUBE |
| 51 | OINTMENT,PAPAIN + UREA, EACH 1gm OF OINTMENT SHOULD HAVE PAPAIN >= IP 100mg & UREA >= 100mg; PREFERRED PACK,15g/TUBE |
| 52 | SYRUP,DISODIUM HYDROGEN CITRATE 1.37gm/5ml, MINIMUM 100ml BOTTLE |
| 53 | SYRUP,LACTULOSE LAXATIVE LIQUID CONTAINING 10G/15ML,400/450 ML/BOTTLE |
| 54 | SYRUP,LAXATIVE LIQUID EACH 15ml CONTAINING MINIMUM STRENGTH/QUANTITY IN EACH OF THE FOLLOWING: LIQUID PARAFFIN 3.75ml + MILK OF MAGNESIA I.P 11.25ml, BOTTLE OF MINIMUM 150 ML |
| 55 | SYRUP,LACTULOSE LAXATIVE LIQUID CONTAINING 10g/15ml,BOTTLE OF 200ml. |
| 56 | SYRUP,SUCRALFATE 1g,100ml/BOTTLE |
| 57 | POWDER,POVIDONE IODINE 5% W/W,PREFERRED PACK SIZE 10gm/BOTTLE |
| 58 | CREAM,HYDROCORTISONE ACETATE FOAM 10 % W/W |
| 59 | SALINE,ORAL,LAXATIVE,45ml X 2 BOTTLE PACKING,EACH 45ml SHOULD CONTAIN MINIMUM STRENGTH /QUANTITY IN EACH OF THE FOLLOWING: MONOBASIC SODIUM PHOSPHATE DIHYDRATE USP 24.417g , DISODIUM HYDROGEN PHOSPHATE DIHYDRATE BP 5.439g, SODIUM BENZOATE IP (AS PRESERVATIVE) 0.2% W/V EXCEPIENTS QS |
| 60 | SOLUTION,PROCTO-CLYSIS ENEMA,100ml/PACK,CONTAINING MINIMUM STRENGTH/QUANTITY IN EACH OF THE FOLLOWING: SODIUM ACID PHOSPHATE I.P 10% W/V, SODIUM PHOSPHATE I.P 8% W/V |
| 61 | BETHANECOL CHLORIDE 50 MG |
